Veracyte grants 44,221 RSUs to senior executive

Haas Kevin Richard reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Haas Kevin Richard reported acquisition or exercise transactions in this Form 4 filing.

VERACYTE, INC. Chief Dev and Tech Officer Kevin Richard Haas received a grant of 44,221 shares of Common Stock on April 10, 2026 as equity compensation. These are restricted stock units awarded at no cash cost to him.

The RSUs vest 25% on June 2, 2027, with the remaining portion vesting in equal 1/16 increments each quarter thereafter, subject to his continued employment on each vesting date. After this grant, he holds 44,221 shares directly according to the filing.

Insider Trade Summary

Grant/Award: 44,221 shares

Grant/Award 1 txn

Insider Haas Kevin Richard

Role Chief Dev and Tech Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	44,221	$0.00	$0.00

Holdings After Transaction: Common Stock — 44,221 shares (Direct)

Footnotes (1)

1. F1. Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

Key Figures

RSUs granted: 44,221 shares Initial vesting date: June 2, 2027 Ongoing vesting pattern: 1/16 per quarter +2 more

5 metrics

RSUs granted 44,221 shares Restricted stock units awarded April 10, 2026

Initial vesting date June 2, 2027 25% of RSUs vest on this date

Ongoing vesting pattern 1/16 per quarter Remaining RSUs vest quarterly after June 2, 2027

Shares held after grant 44,221 shares Direct ownership following the reported transaction

Grant price $0.0000 per share Equity compensation, no cash paid by executive

Key Terms

Restricted stock units, vest, Chief Dev and Tech Officer

3 terms

Restricted stock units financial

"Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest financial

"Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Chief Dev and Tech Officer financial

"Haas Kevin Richard, Chief Dev and Tech Officer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Veracyte (VCYT) report for Kevin Richard Haas?

Veracyte reported that Chief Dev and Tech Officer Kevin Richard Haas received an equity grant of 44,221 Common Stock shares on April 10, 2026. The award was issued at no cash cost as a restricted stock unit grant under the company’s compensation program.

How many Veracyte (VCYT) shares does Kevin Haas hold after this Form 4?

After the reported transaction, Kevin Haas holds 44,221 shares of Veracyte Common Stock directly. This entire balance reflects the newly awarded restricted stock units, which are subject to a multi-year vesting schedule tied to his continued employment with the company.

What is the vesting schedule for Kevin Haas’s 44,221 Veracyte RSUs?

The restricted stock units granted to Kevin Haas on April 10, 2026 vest 25% on June 2, 2027. The remaining units vest in equal 1/16 increments each following quarter, provided he remains employed by Veracyte on each scheduled vesting date.

Did Kevin Haas buy or sell Veracyte (VCYT) stock in this Form 4?

The filing shows an acquisition through a grant, not an open-market trade. Kevin Haas received 44,221 restricted stock units as compensation, with no reported purchase price and no shares sold, indicating a routine equity award rather than discretionary buying or selling.

Is Kevin Haas’s Veracyte (VCYT) equity grant tied to continued employment?

Yes. The RSU award vests only if Kevin Haas continues employment with Veracyte through each vesting date. Twenty‑five percent vest on June 2, 2027, and the balance vests in 1/16 quarterly tranches, reinforcing long-term alignment between his service and equity ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 05:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Haas Kevin Richard

(Last) (First) (Middle)

C/O VERACYTE, INC.

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Dev and Tech Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/10/2026		A(1)		44,221	A	$0	44,221	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	04/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)